巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Fresenius Medical Care AG & Co KGaA

    FMS
    30.420
    0.200
    0.66%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Fresenius Medical Care AG & Co KGaA - 延遲價格・最後更新於 26/05 5:15
    最高位
    30.490
    最低位
    30.200
    開市價
    --
    前收市價
    30.220
    成交量(千)
    7.48
    成交額(百萬)
    2.01
    買入
    30.300
    賣出
    30.380
    每手股數
    --
    市值(百萬)
    17,827.78
    市盈率
    18.990
    息率
    2.33%
    差價
    --
    52週高低
    42.450 - 28.750
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Fresenius Medical Care AG & Co KGaA
    證券代碼
    FMS.US
    所屬板塊
    Medical Care Facilities
    公司業務
    Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
    發行量
    586054558
    公司總部
    Else-Kroener-Strasse 1
    公司網址
    https://www.freseniusmedicalcare.com
    公司電郵
    robert.adolph(at)fmc-ag.com
    公司電話
    +49 61726090
    暫無內容

    關於

    Fresenius Medical Care AG & Co KGaA(FMS.US)所屬的行業板塊為Medical Care Facilities。
    Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
    截至26/05 05:15:52,Fresenius Medical Care AG & Co KGaA的股價升0.66,市值17,827.78百萬。Fresenius Medical Care AG & Co KGaA的市盈率及息率分別為18.990及2.33%。
    詳細公司背景可參考: https://www.freseniusmedicalcare.com